Clinico-pathological and Treatment-related Factors Influencing Survival in Parotid Cancer
Overview
Authors
Affiliations
One hundred and three patients with primary parotid cancer treated surgically at the Christie Hospital, Manchester (1952-1992), were analysed to assess the influence on survival of prognostic and treatment-related factors. Thirty-seven patients were treated by surgery alone (SG), 66 received post-operative radiation (SG+RT). Median follow-up was 12 years, minimum 5 years. The 10-year disease-specific survival rates for stage I, II and III/IV were 96%, 61% and 17% respectively (P < 0.0001). The various histological types segregated into three survival patterns: low-, intermediate-and high-grade with 10-year survival rates of 93%, 41% and 50% respectively (P < 0.0001). On multivariate analysis, the factors influencing risk of cancer death in order of importance were: tumour size > 4 cm (P < 0.001), presence of nodes (P = 0.001), histology of adenoid cystic carcinoma (P = 0.01), high-tumour grade (P = 0.02) and perineural involvement (P = 0.01). Neither the extent of surgery nor the operator influenced outcome. Overall, adjuvant RT significantly reduced locoregional recurrence (SG+RT 15% vs SG 43%; P = 0.002) but not survival, although on subanalysis, there was a trend to improved survival with large cancers and high-grade tumours. Long-term survival is determined primarily by tumour characteristics, namely clinical stage and grade. Post-operative RT contributes significantly to locoregional control and probably confers some survival advantage in high-risk patients.
Tamgadge S, Venkateshwar G, Pereira T, Tamgadge A, Pethani S Ecancermedicalscience. 2024; 18:1776.
PMID: 39430089 PMC: 11489107. DOI: 10.3332/ecancer.2024.1776.
Han S, Lee J, Kang J, Kim H, Lee D, Kim J Clin Exp Otorhinolaryngol. 2024; 17(1):78-84.
PMID: 38228134 PMC: 10933808. DOI: 10.21053/ceo.2023.00014.
Ghaderi H, Kruger E, Ahmadvand S, Mohammadi Y, Khademi B, Ghaderi A J Cancer Epidemiol. 2023; 2023:8844535.
PMID: 38026266 PMC: 10681769. DOI: 10.1155/2023/8844535.
Management and outcome of parotid mucoepidermoid carcinoma by histological grade: A 21-year review.
Taniuchi M, Kawata R, Terada T, Higashino M, Nishimura H, Kurisu Y Laryngoscope Investig Otolaryngol. 2022; 7(3):766-773.
PMID: 35734046 PMC: 9194965. DOI: 10.1002/lio2.809.
A retrospective study of parotid gland tumors at a single institution.
Suzuki S, Bandoh N, Goto T, Kubota A, Uemura A, Kono M Oncol Lett. 2022; 24(1):207.
PMID: 35720490 PMC: 9178697. DOI: 10.3892/ol.2022.13328.